ÇELİK, S. Et Al. 2016. Significance of Pretreatment Testosterone Levels in Prostate Cancer Risk Groups. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.15, no.3 , 98-102.

ÇELİK, S., BOZKURT, O., Yildiz, H. A., Demir, O., Tuna, B., YÖRÜKOĞLU, K., ... ASLAN, G.(2016). Significance of Pretreatment Testosterone Levels in Prostate Cancer Risk Groups. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.15, no.3, 98-102.

ÇELİK, SERDAR Et Al. "Significance of Pretreatment Testosterone Levels in Prostate Cancer Risk Groups," UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.15, no.3, 98-102, 2016

ÇELİK, SERDAR Et Al. "Significance of Pretreatment Testosterone Levels in Prostate Cancer Risk Groups." UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.15, no.3, pp.98-102, 2016

ÇELİK, S. Et Al. (2016) . "Significance of Pretreatment Testosterone Levels in Prostate Cancer Risk Groups." UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.15, no.3, pp.98-102.

@article{article, author={SERDAR ÇELİK Et Al. }, title={Significance of Pretreatment Testosterone Levels in Prostate Cancer Risk Groups}, journal={UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY}, year=2016, pages={98-102} }